Is Jagsonpal Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Jagsonpal Pharmaceuticals pays dividends. Last time was Friday 18th of October 2024 where the investors holding the stock on Friday 6th of September 2024 were paid INR5 per share. Over the last 22 times between 2003 and 2024, Jagsonpal Pharmaceuticals has paid INR24.95 with an average of INR1.13 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Jagsonpal Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR22.80, you would have made a profit of INR391.00 per share or 1 714.91%
Yes, the average daily trading liquidity for Jagsonpal Pharmaceuticals is INR77 693 thousand. You should therefore be able to get in and out of your positions relatively fast.
Jagsonpal Pharmaceuticals has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.13, the company's ability to pay off the debt is good. Jagsonpal Pharmaceuticals has a good net profit margin of 10.76% and should have high tolerances against inflation.
We have calculated the inflation risk for Jagsonpal Pharmaceuticals to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.